4.6 Controlled Substance Inventory & Record Reconciliation

Controlled Substance Inventory & Record Reconciliation

Outline task 3A4—and the related purchasing/record duties in 3A2–3A3—tests whether you can keep controlled substances accountable from order to disposition. Federal DEA inventory rules set a baseline; California’s 16 CCR § 1715.65 imposes more frequent, formal inventory reconciliation reports designed to detect diversion. CPJE items often hinge on timing (quarterly vs annual vs biennial), physical count versus perpetual-system estimate, and what a new pharmacist-in-charge must do in the first 30 days.

Record Trail: Ordered, Received, Stored, Removed

A defensible CS record system links every acquisition to every disposition:

1. Ordering / DEA Form 222 or CSOS for Schedule II procurement; invoices and packing slips for Schedules III–V as applicable.
2. Receipt verification — count and identity check on arrival; document discrepancies with the supplier immediately.
3. Storage — secure C-II storage (locked cabinet/safe as required), limited access, and perpetual logs where used for high-risk stock.
4. Removal from inventory — dispensing, compounding withdrawals, returns, spillage/waste, transfers, and outdates—each with a matching record.

Perpetual inventory systems (common for C-IIs) update on-hand quantity with every transaction. They are excellent diversion sensors only if counts are truthful and discrepancies are investigated. California reconciliation rules still require physical counts for covered substances; you generally cannot substitute a perpetual-log estimate for the physical count on a § 1715.65 reconciliation report (with limited ADDS accounting exceptions for inpatient hospital and licensed correctional pharmacies).

Maintain purchase, receipt, and disposition records so they are readily retrievable for the retention period required by state and federal law (California pharmacy practice commonly emphasizes multi-year ready retrieval; reconciliation reports specifically must be kept three years under § 1715.65).

Federal DEA Inventory Baseline

Under DEA rules (21 CFR § 1304.11):

• Take an initial inventory when first engaging in controlled substance activity.
• Take a new inventory at least every two years (biennial inventory).
• Inventories must be actual physical counts for Schedule II; for III–V, estimates are federally permitted in some cases, though exact counts are best practice and may be required by stricter state/policy rules.
• Exact timing, open vs close of business notation, and signature/date formalities matter for DEA compliance.

Exam contrast: Meeting the DEA biennial inventory does not satisfy California’s more frequent § 1715.65 reconciliation schedule for Schedule II and specified non-II products.

California Inventory Reconciliation: 16 CCR § 1715.65

Revisions effective January 1, 2023 require every pharmacy—and clinics licensed under B&P §§ 4180 or 4190—to perform inventory activities and prepare inventory reconciliation reports to detect and prevent losses of federal controlled substances.

Frequency (High-Yield)

Inpatient hospital pharmacies have explicit expectations to include CS under pharmacy control across the facility (pharmacy, satellites, and drug storage areas stocked by the pharmacy). For ADDS stocked by inpatient hospital or licensed correctional pharmacies, § 1715.65 allows accounting by means other than physical count for the ADDS portion—do not incorrectly extend that exception to ordinary community pharmacy shelves.

What Must Be Inside the Reconciliation Report

At minimum, a compliant report includes:

• A physical count, not an estimate, of each covered controlled substance.
• Signatures/dates of individuals who performed the inventory.
• Review of all acquisitions and dispositions since the last reconciliation covering that substance.
• Comparison of physical count to the acquisition/disposition math (identify shortages/overages).
• Identification of records used; identification of individuals preparing the report.
• Possible causes of overages; written identification of losses and known causes.
• Dating and signature by the pharmacist-in-charge (or clinic professional director as applicable).

The PIC must review inventory activities/reports and maintain written policies and procedures that establish secure methods to prevent losses. Reports and compiling records must be readily retrievable for three years.

PIC Transition Rules

Under § 1715.65(f):

• A new PIC must complete an inventory reconciliation report for all federal Schedule II substances and the specified alprazolam/tramadol/promethazine-with-codeine products within 30 days of becoming PIC.
• An outgoing PIC should complete that reconciliation whenever possible before leaving.

These PIC transition inventories are classic CPJE setups: a new PIC who “inherits” the perpetual log without a physical reconciliation is already out of compliance.

Losses, Missing Counts, and Exam Scenarios

Couple § 1715.65 with 16 CCR § 1715.6 loss reporting and B&P § 4104 theft/impairment reporting concepts:

• Investigate variances immediately—do not “adjust the perpetual” silently.
• Reportable losses to the Board are generally due within 30 days of discovery; if caused by theft, diversion, or self-use, notify the Board within 14 days of discovery.
• Federal DEA Form 106 obligations may apply in parallel for significant theft/loss.

Common exam vignettes and correct instincts:

1. C-II count short versus perpetual log: quarantine access patterns, review dispense/waste/transfer records, perform reconciliation math, notify PIC, report if thresholds/patterns met—do not wait for the next biennial DEA inventory.
2. Using shelf estimate for quarterly C-II reconciliation: invalid; physical count required.
3. Assuming annual alprazolam 0.5 mg tabs follow the special annual list: the special annual list is strength-specific (1 mg and 2 mg units for alprazolam); other strengths fall under the general “other CS” activity rules unless a loss triggers reconciliation.
4. New PIC day 45 with no C-II reconciliation: late—30-day requirement already missed.
5. Hospital ADDS vs community ADDS: only the regulation’s specified settings may use non-physical ADDS accounting methods; community pharmacies should not claim a blanket ADDS exception.

Operational excellence means treating reconciliation as a diversion-detection system, not a paperwork ritual. Patterns of small repeated losses, after-hours access anomalies, and “corrected” counts without investigation are Board red flags even when a single event is below a numeric threshold.